HB1418: Animal Drug and Animal Generic Drug User Fee Amendments of 2023
- Introduced (completed)
- 2Passed One Chamber (current step)
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs and generic new animal drugs.
Plain-language summary
This bill reauthorizes user fee programs for animal drugs and generic animal drugs under the Federal Food, Drug, and Cosmetic Act. User fees are charges that companies pay to the FDA when they submit applications for new animal medicines or generic versions of animal medicines. These fees help fund the FDA's review process for these drug applications. The bill has passed both the House and Senate and is ready to be signed into law.
AI-generated summary
What can I do?
This bill is halfway there — legislators in the second chamber are considering it now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
HB1418: Animal Drug and Animal Generic Drug User Fee Amendments of 2023